Navigation Links
NEWSWEEK: Cover: Giving Globally: How to Heal the World
Date:9/23/2007

Bill Gates on Fighting Diseases Like Malaria and Tuberculosis: 'The

Evidence is in: These Problems can be Solved' 'I'm Now More Convinced Than Ever That we Can Create a Healthier World for

Everyone'

Newsweek Profiles Four Innovators Working to Bring Vaccines to the Developing World, Beating Science, Logistics and Financing Challenges

NEW YORK, Sept. 23 /PRNewswire/ -- Microsoft cofounder Bill Gates writes in the current issue of Newsweek that progress is being made in worldwide health initiatives for developing countries, with governments, aid groups and communities "simply refusing to accept the notion that diseases like malaria and tuberculosis will haunt us forever. The evidence is in: these problems can be solved."

(Photo: http://www.newscom.com/cgi-bin/prnh/20070923/NYSU001 )

Gates' essay is part of the October 1 Newsweek cover "Giving Globally: How to Heal The World" (on newsstands Monday, September 24). "I believe we stand at a moment of unequaled opportunity," he writes. "Governments must now step up to the plate with more money-wisely targeted-to expand effective global health programs to reach all those in need. Businesses, community groups and individuals all play a role as well ... I'm now more convinced than ever that we can create a healthier world for everyone."

In the cover package, General Editor Mary Carmichael profiles four innovators who are working to bring lifesaving vaccines to children around the world. When it comes to immunization, much of the developing world is still stuck in the 18th century. In vast parts of rural Africa, Asia and Latin America, kids don't get any of the basic vaccines available in developed countries; they die because of that fact. And no one anywhere gets routinely and effectively immunized against the big global killers-HIV, tuberculosis and ma
'/>"/>

SOURCE Newsweek
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Giving up smoking is good for health, but causes weight gain too
2. Women who conceive after a year have a higher chance of giving birth prematurely
3. Women who conceive after a year have a higher chance of giving birth prematurely
4. Canada helps in giving birth to world first baby from frozen egg
5. Need for considering cardiovascular risks before giving HAART for HIV/aids patients
6. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
7. Help teenagers eat healthy by giving nutritional information along with food.
8. Holiday giving linked to altruistic nature of our ancestors
9. Teachers not comfortable in giving sex education: PU Study
10. Pharmaceutical Companies Banned from Giving Gifts at Stanford
11. Parents to Exercise Caution While Giving Cold Medicine to Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)... are being urged to think before they drink as par...binge drinking habits. , A team of health psycho...scover whether using the workplace to supply infor... asking employees for a small commitment to reduci... change peoples binge drinking behaviour in the lo...
(Date:5/12/2008)...ted gene has been discovered as the key behind epi...anks to new research at Adelaides Womens & Childre...lia. , The world-first discovery, published toda...y the bad gene, only women are affected. , The r...ciate Professor Jozef Gecz from the Department of ...
(Date:5/12/2008)...OUTH MEETING, Pa., May 12 /Xinhua-PRNewswire-First...,BMP Sunstone, or the ,Company,),one of China,...l companies,today announced that it plans to rele..., May 19, 2008, before the market opens., The Com...:00 am ET to,discuss fiscal first quarter 2008 res...
(Date:5/12/2008)...I PROVINCE, China, May 12 /Xinhua-PRNewswire-First...Board: BPMA), a China-based,pharmaceutical company...e,therapy medicine for the treatment of cancer, an...today announced that it has appointed Jun Tang to,...r. Tang has over a decade of experience in corpora...
Breaking Medicine News(10 mins):Health News:Think before you drink, says university research 2Health News:Mutant gene causes epilepsy, intellectual disability in women 2Health News:BMP Sunstone to Report First Quarter 2008 Financial Results 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 3
...a reports on dubious medical stories can harm the ...in the British Medical Journal//. Media reporting ...ated with a fall in donations for ethically approv...ds a study in latest BMJ. This analysis shows how ...
...5. A researcher in New Zealand has developed a de... suffer from sleep apnoea, where breathing stops d...of problems from high blood pressure and diabetes ...on the strife and misery caused by snoring partner...
...s not discriminate between rich and poor, if not d...s have succumbed to it and some have fought it and...actresses and personalities who have suffered from...n -Actress and SingerShirley Temple Black - Actres...
...Cedars-Sinai Medical Center had developed a device...o detect the inflammation that is //part of plaque...w, in a study involving laboratory rabbits, a devi...res light emissions from body tissues has been abl...
Other Medicine News:Health News:A Cheap Device to Stop Snoring from New Zealand 2Health News:Researchers Develop Device For Detecting Atherosclerotic Plaques 2
(Date:5/9/2008)...wswire/ -- The risk of the two major,prostate dise...), can be,reduced by changes in lifestyle, such as... eating a healthy diet. Alan Kristal, Dr.P.H., ass...ed Hutchinson Cancer Research,Center in Seattle, h...t,feel helpless against prostate cancer or BPH.,...
(Date:5/8/2008)...rstCall/ -- DATATRAK International, Inc.,(Nasdaq: ... on global,eClinical solutions for the clinical tr...s for the first quarter of 2008., For the three m...oximately 41% to $2,088,000 and the Company report...e on both a basic and diluted basis. These,results...
(Date:5/8/2008)...FirstCall/ -- Alpharma Inc. (NYSE: ALO ),a globa...d results from,clinical trials that showed ALO-01 ...th sequestered naltrexone hydrochloride) capsules,...ng abuse liability,alongside a promising safety an...esented at the 27th Annual Scientific Session of t...
(Date:5/8/2008)...s on Use of Pro-Healing Stent with AMI Patients...herapy, HONG KONG, May 8 /- Twelve-m...tudy and the real-world registry use of OrbusNeich...t pro-healing stent, will be,presented next week i..., The symposium, titled "Clinical Impact of the P...
Breaking Medicine Technology:Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2Cells united against cancer 161 1Cells united against cancer 161 2Giving CPR Kits to Kids Nudges Parents to Learn 206 1Giving CPR Kits to Kids Nudges Parents to Learn 206 2Scientists identify embryonic stem cells by appearance alone 158 1Scientists identify embryonic stem cells by appearance alone 158 2Scientists identify embryonic stem cells by appearance alone 158 3Obesity Rate in U S Still Climbing 201 1Obesity Rate in U S Still Climbing 201 2Obesity Rate in U S Still Climbing 201 3Obesity Rate in U S Still Climbing 201 4
...stCall/ -- Vanda,Pharmaceuticals Inc. announced to...Sleep Disorders and Research Center in Detroit, MI...e III clinical,trial results for VEC-162, Vanda,s ...SLEEP 2007, the 21st annual meeting of the,Associa...nda presentation will take place at the Convention...
...tion during the,early post-operative period compar...tion in nausea in the female,patient population co...- CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambri...itional data from post-hoc analysis of the recent ...onide) in over 500 patients,with post-operative pa...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: